Abstract
Follicular non-Hodgkin’s lymphomas consist of the follicular centroblastic-centrocytic lymphomas (Kiel classification) and of the follicular small cleaved (FSC), follicular mixed (FM), and follicular large cell (FLC) lymphomas (International Working Formulation, IWF). The FSC and FM subtypes forming the majority of follicular lymphoma are considered to be of low-grade malignancy whereas the FLC subtype is classified as intermediate. About one third of all the patients with NHL have a follicular histology with a median age of over 50 years.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
. Mc Laughlin P, Fuller LM, Velasquez WS et al: Stage III follicular lymphoma: durable remissions with a combined chemotherapy-radiotherapy regimen. J Clin Oncol 5: 867 – 874, 1987.
. Mendenhall NP, Noyes WD amd Million RR: total body irradiation for stage II–IV non-Hodgkin’s lymphoma: ten-year follow-up. J Clin Oncol 7: 67 – 74, 1989.
. Armitage JO: Bone marrow transplantation in the treatment of patients with lymphoma. Blood 73: 1749 – 58, 1989.
. Rohatiner AZS, Price CSA, Arnott S et al: Ablation therapy with autologous bone marrow transplantation as consolidation of remission in patients with follicular lymphoma. in Dicke K (ed): Autologous Bone Marrow Transplantation. Proc Fifth Int. Symp, 1991, pp 465 – 471.
. Schouten HC, Sanger WG and Armitage JO: Chromosomal abnormalities in malignant lymphoma and Hodgkin’s disease. Leukemia and Lymphoma 5: 93 – 100, 1991.
. Lee MS, Chang KS, Cabanillas F et al: Detection of minimal residual cells carrying the t(14; 18) by DNA sequence amplification. Science 237: 175 – 178, 1987.
. Gribben JG, Freedman AF, Newberg D et al: Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N. Engl. J. Med. 325: 1525 – 1533, 1991
. Takvorian T, Canellos GP, Ritz J et al: Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin’s lymphoma with a poor prognosis. N Eng J Med 316: 1499 – 1505 1987.
. Kvalheim G, Sotrensen D, Fodstad O et al: Immunomagnetic removal of B–lymphoma cells from human bone marrow: a procedure for clinical use. Bone Marrow Transp 3: 31 – 41 1988.
. Nadler LM, Takvorian T, Botnick L et al: Anti-B 1 monoclonal antibody and complement treatment in autologous bone marrow transplantation for relapsed B-cell non-Hodgkin’s lymphoma Lancet 2: 427 – 431, 1984.
. Kiesel S, Pezzutto A, Haas R et al: Functional evaluation of CD 19 and CD22-negative variants of B-lymphoid cell lines. Immunology 64: 445 – 450, 1988.
. Straka C, Drexler E, Mitterer M Langenmayer I, Pfeffernkorn L., Stade B, Koll R and Emmerich B: Autotransplantation of B-cell purged peripheral blood progenitor cells in B-cell lymphoma. The Lancet, 345: 797 – 798, 1995.
. Clift RA, Duckner CD, Thomas ED et al: The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation. Bone Marrow Transp. 2: 243 – 248, 1987.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Plenum Press, New york
About this chapter
Cite this chapter
Porcellini, A., Schouten, H., Stade, B., Koll, R. (1996). European Cup Trial. In: Abraham, N.G., Asano, S., Brittinger, G., Maestroni, G.J.M., Shadduck, R.K. (eds) Molecular Biology of Hematopoiesis 5. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0391-6_16
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0391-6_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-8031-3
Online ISBN: 978-1-4613-0391-6
eBook Packages: Springer Book Archive